Numerous genetic mutations are linked to increased risk for breast cancer. Genetic testing can identify these mutations and guide patient management decisions. Over the past decade, multi-gene panel tests have gained traction in clinical settings. These evaluate up to 43 breast cancer-related genes, compared with limited BRCA 1 and BRCA2 (BRCA1/2) tests.
Nimmi Kapoor, MD, a fellowship-trained, board-certified oncology surgeon, has been appointed Medical Director of Breastlink at the Encino Breast Care Center. Breastlink will relocate to the Integrated Cancer Institute upon the opening of its doors next year.
Every October, individuals and entities across the nation participate in an annual campaign to increase awareness of breast cancer. Breast cancer is the most common non-skin cancer in women and a leading cause of cancer death. The American Cancer Society estimates that approximately 230,000 women will be diagnosed with breast cancer in 2015 and that around 40,000 will die from this disease. This year, learn how you can reduce your risk for breast cancer by eating healthy and living a physically active lifestyle.
Mammography uses X-ray technology to produce images of breast tissue. These images can reveal tumors and other abnormalities, such as lumps and calcifications. As a screening exam, mammography is proven to save lives. Many health care professionals and organizations, including the American Cancer Society, agree that women should be screened annually beginning at age 40.